Special Edition Mid-week WATCHLIST

Low float biotech bonanza!                                                                                                                                                                      Good Morning! Low-float biotechs are HOT right now — on Monday we had at least five running in premarket. Yesterday we had another five… And they’re all gaining 50%, 100%, and even more than 200%! Reviewing these big moves after the fact can help you recognize patterns and look for better entries and exits… But to capitalize on the momentum while it’s here, you have to spot the big runners and make trading plans before the moves happen. So to help you do that, I’m giving you a special mid-week biotech watchlist. Let's not waste any time getting ready for the potential moves we could see today… Biotech Stocks To Watch This Week When you're looking at recent runners and trying to determine which stocks should stay on your watchlist, look for stocks that are hanging around. Strong stocks that have held their gains. That can be tough with biotech stocks since they tend to be one-and-done spikers. ([That’s why you need to remember this lesson]( But these stocks can have some epic Friday squeeze potential if they hang around the rest of the week… So I’ll show what’s been hot this week and what to potentially watch them for… But to find your best trades each morning — use your [StocksToTrade scanners]( to find low-float biotechs with news. HeartCore Enterprises, Inc. (NASDAQ: [HTCR]( HTCR has a [low float]( of fewer than five million shares and it traded over 85 million shares yesterday. The stock gained over 160% after announcing [earnings](. It [failed VWAP]( yesterday afternoon but then formed a support level. If this holds up today and consolidates, it could be a potential [squeeze candidate]( heading into the end of the week. I think it needs to at least be over $3 before shorts start to get nervous. HTCR chart: 2-day, 5-minute candle — courtesy of [StocksToTrade.com]( CohBar, Inc. (NASDAQ: [CWBR]( CWBR was so close to becoming my number-one watch yesterday… But I didn’t love [the news](. And it just kept ripping higher in premarket so I didn’t see an edge there to plan a morning trade. I kept hoping for any kind of pullback or slowdown so it would lure in shorts and I could make a plan… I did slow down all morning so I made it [my Daily Double Down]( pick. It was a chat pump survivor and it was loaded up with shorts. The stock formed a base, then reclaimed VWAP and [broke the high of the day]( at 1 p.m. Eastern. So again, waiting for the afternoon was the best approach. I like that CWBR held VWAP into the close and the $4.50 level that was my long signal yesterday. Watch for a [break above $6.50](. CWBR chart: 1-day, 5-minute candle — courtesy of [StocksToTrade.com]( AVROBIO, Inc. (NASDAQ: [AVRO]( AVRO was one of the big spikers on Monday. It’s not a low-float stock — it has roughly 40 million shares in the float… But that could make it even more appealing to short sellers. The stocks gained almost 120% on Monday after announcing an agreement to sell one of its gene therapies for [$87.5 million cash](. The stock couldn’t hold all of its gains on Monday. But the big gap up on the daily chart and the fact that this has held up and consolidated for two days makes me think it’s full of shorts. This could have the potential to squeeze and break out later this week. It looks like it’s setting up for a potential [day-three surge](. And shorts will probably get nervous around the $1.50 to $1.70 level. But it will need volume to be able to have a big move. AVRO chart: 2-day, 5-minute candle — courtesy of [StocksToTrade.com]( Microbot Medical Inc. (NASDAQ: [MBOT]( Who could forget MBOT? This low-float biotech gained 250% on Monday after announcing a [100% success rate]( in its animal study. And even after it announced nasty mid-day [offering news]( the stock still held up. Yesterday it was looking good when it managed to make a brief red-to-green move. But it ended up closing weaker than I’d like. Keep this one on watch towards the end of the week for a potential squeeze. But if it dies, it dies… MBOT chart: 2-day, 5-minute candle — courtesy of [StocksToTrade.com]( MBOT chart: 2-day, 5-minute candle — courtesy of [StocksToTrade.com]( Get ready for any potential game plans with my [Market Update videos]( three times per week. If you want more timely trade ideas and plans — [sign up for my daily morning alert and trade plan, plus, my top afternoon pick that I go over LIVE]( Have a great day everyone. See you back here tomorrow. Tim Bohen Lead Trainer, StocksToTrade   sponsored   This 24-Year-Old Went From Broke to $1.4 Million… 24-year old Matt Monaco was like most college students. Studying in college, broke, and worried about landing a 9-to-5 job… until he discovered this 3-Step System! After only two years Matt collected over 1.4 MILLION dollars from trading… And it’s all because of something called “Oracle.” [Go here now to find out how you can start following Oracle’s 3-Step System today.]( sponsored   Discover the Potential $23 Trillion Market Tesla Could Be Entering! I've uncovered three patents pointing to groundbreaking news that could be announced any day now. And don't worry if you trade with a small account — there are five ways you could take advantage of this opportunity too. [Get the details before it's too late!](   Recommended Membership Gifts   ACCESS NOW: Click to activate these complimentary membership gifts and receive daily market intel. [To The Moon Report Weekly Stock & Crypto Watchlist]( [Mark Croock Evolved Trader Daily](     [Facebook]( [Twitter]( [Instagram]( [YouTube]( [Spotify]( [Click Here to Unsubscribe]( (As an Amazon Associate, we earn from qualifying purchases.) 13809 Research Boulevard, Suite 500, Austin, TX 78750 *Please note that these kinds of trading results are not typical. Most traders lose money. It takes years of dedication, hard work, and discipline to learn how to trade, and individual results will vary. Trading is inherently risky. Before making any trades, remember to do your due diligence and never risk more than you can afford to lose. This is for informational purposes only as StocksToTrade is not registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. StocksToTrade cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. StocksToTrade in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, StocksToTrade accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns. Copyright © StocksToTrade.com